Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Lepu Medical Technology Beijing Co Ltd's latest stock split occurred on Jun 23, 2016
The company executed a 20-for-10 stock split, meaning that for every 10 shares held, investors received 20 new shares.
Before the split, Lepu Medical Technology Beijing Co Ltd traded at 36.3 per share. Afterward, the share price was about 16.7596.
The adjusted shares began trading on Jun 23, 2016. This was Lepu Medical Technology Beijing Co Ltd's 2nd stock split, following the previous one in May 18, 2010.
1S9
Lepu Medical Technology Beijing Co Ltd
Glance View
Lepu Medical Technology Beijing Co Ltd. was born in the vibrant landscape of China's rapidly evolving healthcare industry. Established in 1999, the company has grown into a formidable player in the medical device sector. It carved its niche by focusing on cardiovascular interventions, technological innovations, and pharmaceuticals. At its core, Lepu Medical thrives on leveraging its research and development expertise to create products that cater to a broad spectrum of medical needs, particularly in the cardiovascular domain. They manufacture and distribute a wide range of medical devices which include coronary stents, pacemakers, and other related products, enabling them to secure a strong foothold in both domestic and international markets. Revenue generation for Lepu Medical is a multifaceted process that leverages the company's comprehensive vertical integration strategy. The company has strategically developed a robust portfolio not only in medical devices but also in pharmaceuticals and healthcare services. This diversified offering allows them to capture value across the entire patient care continuum—from device manufacturing and pharmaceuticals to post-operative care and services. By continually investing in innovation and expanding their reach through strategic partnerships and acquisitions, Lepu Medical ensures a consistent revenue stream, reinforcing its position within the global healthcare landscape. The company's commitment to quality and technological advancement keeps it competitive, propelling its growth across various health sectors.
You don't have any saved screeners yet